MYC overexpression with its prognostic and clinicopathological significance in breast cancer

MLA

Yan Yan, et al. “MYC Overexpression with Its Prognostic and Clinicopathological Significance in Breast Cancer.” Oncotarget, vol. 8, Oct. 2017, pp. 93998–4008. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....fdd2942e2a0d05630a578001ae155105&authtype=sso&custid=ns315887.

APA

Yan Yan, Lin Liu, Jiansheng Wang, Xixi Zhao, Jia Zhang, Hui Cai, Hang-Ying Qu, Ning Lu, Jizhao Wang, Xu Liu, Jingkun Qu, Yuchen Sun, & Feidi Wang. (2017). MYC overexpression with its prognostic and clinicopathological significance in breast cancer. Oncotarget, 8, 93998–94008.

Chicago

Yan Yan, Lin Liu, Jiansheng Wang, Xixi Zhao, Jia Zhang, Hui Cai, Hang-Ying Qu, et al. 2017. “MYC Overexpression with Its Prognostic and Clinicopathological Significance in Breast Cancer.” Oncotarget 8 (October): 93998–8. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....fdd2942e2a0d05630a578001ae155105&authtype=sso&custid=ns315887.